Mario Lacouture

19PUBLICATIONS
83CO-AUTHORS
Environmental epidemiologyImmunogenetics (incl. genetic immunology)Major global burdens of diseasePredictive and prognostic markersCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 05, 2026
Benralizumab relieves Eosinophil-Related Cutaneous Adverse Events from Cancer Therapy: A Nonrandomized Phase 2 Trial.

|Dec 16, 2024
Phenotype/Immunologic Profiling in ircAEs-Response.

Elena Goleva, Mario E Lacouture, Andrea P Moy

|Oct 26, 2024
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.

Z Apalla, A Freites-Martinez, K Grafanaki

|Oct 09, 2024
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.

Megan H Trager, Alyce M Kuo, Stephen W Dusza

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

|Dec 07, 2023
Supportive oncodermatology practices in Europe and the USA.

Azael Freites-Martinez, Zoe Apalla, Davide Fattore

Pageof 4

Frequent Collaborators

4 joint publications

Lukas Kraehenbuehl

3 joint publications

Andrea P Moy

3 joint publications

Zoe Apalla

3 joint publications

Davide Fattore